We have previously shown that a model of anaesthetic uptake and distribution, developed for use as a teaching tool, is able to predict end-tidal isoflurane and sevoflurane concentrations at least as well as commonly used propofol models predict blood levels of propofol. Models with good predictive performance may be useful as part of real-time prediction systems. The aim of this study was to assess the performance of this model with desflurane.
We have previously described the validation of a nine compartment model of anaesthetic uptake and distribution with isoflurane and sevoflurane 1 . Our results suggest this model predicts end-tidal (eT) isoflurane and sevoflurane at least as well as models used in target controlled infusion (TCI) systems predict blood propofol concentrations. We have used this model to explore the theoretical questions, such as relationship between cardiac output and volatile uptake 2 and to develop practical tools to guide the administration of inhalational anaesthetic agents 3, 4 .
Our system to guide inhalational administration uses past and current fresh gas and vaporizor settings to display predictions of end-tidal and estimated effect site concentrations for the next 10 minutes. These predictions are embedded in a comprehensive trend display and allow the anaesthetist to make step changes in eT levels more rapidly 3 . This type of prediction allows levels of anaesthetic to be more closely matched to changing patient needs and facilitates the use of low fresh gas flows. The system is, however, dependent on the use of a suitable model of the kinetics of the agent in use to make the forward predictions.
The model was originally developed as a teaching tool with halothane 5 and as such has several well recognised limitations that were addressed in later and more sophisticated models. These include using continuous rather than cyclical ventilation and cardiac output, pooling blood and lung volume into a single compartment, and not modelling blood transit times. Despite these limitations, the model performed well with sevoflurane and isoflurane. The aim of the current study was to assess the predictive performance of this model with desflurane, both to assess the performance of the model with different agents and to allow extension of the prediction system to other agents.
MeTHODS
The study was approved by the Canterbury ethics Committee. Written informed consent was obtained from each patient. Twenty adult patients undergoing routine anaesthesia where desflurane was the primary anaesthetic agent were studied. The anaesthetist in charge of the case was given no particular instructions or guidelines as to how to administer the anaesthetic or the choice of other agents. One of the investigators (SG-See Acknowledgement) was present throughout each case to oversee data collection, but took no part in administration of the anaesthetic.
The total fresh gas flow (FGF) and vaporizor settings were recorded by a computer from the anaesthetic machine (Datex ADU, Helsinki, Finland) every 10 seconds throughout the case, along with measured eT values from the anaesthesia monitor (Datex A/S3). Fresh gas flow and vaporizor setting were used as inputs to the uptake model.
Desflurane uptake and distribution was modelled using a multiple compartment model based on that described by Heffernan et al 5 . The model is similar to those of Mapleson 6, 7 , containing nine compartments: circuit; lung/blood, heart, brain, kidney, liver, muscle, fat, and poorly perfused tissues. The model has been extended to include a number of volatile agents 2 and has recently been described in greater detail [1] [2] [3] [4] . The model does not include compartments to mimic blood transit time 7, 8 .
Other parameters of the model, including the size of tissue compartments and relative blood flows were as originally described by Heffernan et al 5 . Blood/gas and tissue/blood partition coefficients are those we have used previously 2, 9 . The model is initialized for the chosen agent and then values for compartment sizes, cardiac output and ventilation used in the model are adjusted for the weight of the patient.
The model calculates a predicted eT value at each 10s iteration. This was compared with the measured values using the statistical method described by Varvel et al 10 Data from the first five minutes of each case were excluded, since models of this type are not able to track breath-by-breath changes and are thus unreliable around major changes. Data from the last five minutes of the case were also excluded for this reason and because a predicted value close to zero makes the various performance measures overly sensitive to changes in the predicted value. Data from all patients were combined by calculating means and 95% confidence intervals (CI). These results were then compared with accepted values for a useful computer controlled infusion system (MDPe <20% and MADPe <40%) 11 .
ReSULTS
Data from one subject were excluded due to equipment problems. The remaining patients were aged 16 to 86y (mean 58y) and weighed 51 to 98 kg (mean 77 kg). The duration of anaesthesia ranged from 51 to 116 min with a mean of 92 min (SD 29 min). All patients were ASA PS I, II or III. Figure 1 shows the various measures of model performance for all subjects. Table 1 shows the means and CI for these measures and includes our results with sevoflurane and isoflurane for comparison. The mean value for MDPe was 78.2% (SD 35.6) and for MADPe 77.5% (SD 36.6). These values were large, with considerable variability between subjects, and were outside suggested limits for a control system. Mean divergence was low (10%/h) but this parameter had considerable variability (SD 46%/h). Wobble was low with a mean of 8.9% (SD 7.6%). 
DISCUSSIOn
Computer models are powerful tools which permit the study of problems and interactions that are difficult to observe directly. For example, we have used this model of volatile anaesthetic uptake and distribution to explore the effects of cardiac output changes that are not immediately obvious 2 . Validation of the model underlying such simulations gives weight to the results of the simulation. Modern electronic anaesthetic machines, such as the Datex ADU, export FGF and vaporizor settings almost continuously. This makes validation of a model in a clinical setting straightforward and allows validation experiments to be conducted during routine anaesthesia, which may involve a variety of FGF rates. Recent reports of the validation of other volatile anaesthetic models mostly relate to a totally closed circuit, often with direct injection of the anaesthetic agent into the circuit, so may not be as applicable to routine practice. Our previous validation exercise with this model using isoflurane and sevoflurane performed at least as well as various models for propofol 1 . The current results, however, show that the model performed poorly using desflurane.
We have developed a predictive system to guide target control of volatile anaesthesia 3,4 based on the model used in this assessment. Swinhoe 11 has suggested that a model is acceptable for use in a TCI system if the absolute value of MDPe is less than 10 to 20% and MADPe <40%. Typical studies of propofol models report mean values for MADPe of around 20% and MDPe between -12% and 16%. Our results for desflurane fall well outside these values. In contrast, our results with sevoflurane and isoflurane suggested this model performs better with these agents than readily available propofol delivery systems.
We agree with Varvel et al 10 that stability within an individual patient is more important than the absolute error (or bias) of a model. The user of a predictive system adjusts the system to achieve a given effect and is not overly concerned about the absolute blood level. However, once the desired level is achieved, it is expected that this level is maintained. This argument suggests that "wobble" and particularly "divergence" are more important than MDPe or MDAPe in assessing predictive performance of a model.
Divergence is a measure of the stability of the model over time. The mean divergence in this data is 10%/h representing a 1.67% error over 10 min. Assuming a typical eT desflurane value of 6 vol%, this represents an error in prediction of around 0.1 vol% over a 10 minute period, which may be acceptable. However the CI for divergence is -80% to 106%, which is 8 to 10 times the mean value. Thus, although the pooled variability may be satisfactory, the wide range of divergences (as illustrated in Figure  1 ) make this model in its current form unreliable with desflurane. Lerou et al have modelled desflurane in a closed circuit with satisfactory results 12 . This group use their own method of analysis, so it is not possible to directly compare results. It is a problem with studies of volatile models that each group uses a different method of analysis. We chose to use the method of Varvel et al 10 , which has become standard for intravenous infusion systems, since this allows comparison between different models and drugs. Despite the inability to make direct comparisons, the model used by Lerou et al 12 would appear to perform much better with desflurane than the model we are using.
The calculation of Pe, which is the basis of the various parameters of model fit, involves division by the predicted eT values. These will be low at the beginning and end of a case and will exaggerate the error that flows from the inability of the model to track changes on a breath-by-breath basis. The first and last five minutes of the anaesthetic were excluded from the analysis for these reasons and to provide consistency with our previous studies. However, eT values were not held constant during these cases and changes occurred frequently. Figure 3 shows the distribution of eT values in the first nine cases.
Determining the reasons why this model performs well with some agents but poorly with desflurane R. Kennedy may help define the necessary characteristics for adequate model performance with a particular agent or in given circumstances. A list of possible reasons for the poor performance of this model is given in Table 2 . A number of patient characteristics that one Model of anaesTheTic UpTaKe figURe 3: Measured end-tidal (eT) desflurane levels for the first nine subjects. Data was sampled every 10s with each point representing one sample. The density of points increases with the amount of time spend in the vicinity of a given eT value. The occurrence of a number of dark bands within data for a subject illustrates that several different eT desflurane levels were maintained at different stages of the case. might expect to be important, such as age, weight, height and cardiac output, have been shown to not significantly affect model performance 13, 14 . However these studies use pooled data from a number of subjects and it may be that individual variability in the capacity of various tissue compartments is a significant factor with desflurane. Many of the other factors listed in Table 2 might be expected to produce a degree of offset, but do not explain the variability, especially when compared to the results for isoflurane and sevoflurane. Although this model does not include transport delays, Mapleson 7 has suggested these factors are only important briefly around large changes. Despite these observations, it may be that different factors are important with different volatile anaesthetics. Data collected during this study will allow us to explore different models and different versions of models in an attempt to discover the essential characteristics for a model that performs adequately with desflurane.
In summary, we have previously shown that a model of volatile anaesthetic uptake developed as a teaching tool performs very well with sevoflurane and isoflurane. However the same model performs no arterial -> eT gradient no inter-tissue diffusion no metabolism tissue solubility coefficients vary regional blood flow variations very poorly with desflurane. The reasons for this difference are not clear. elucidating the causes of the difference between agents may help define the essential characteristics of this type of model.
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